RABEPRAZOLE Detail

Drug Name(s):
RABEPRAZOLE

FDA Application No.:
NDA 076822

Active Ingredient(s):
RABEPRAZOLE SODIUM

Company:
TEVA PHARMS

Original Approval or Tentative Approval Date:
February 14, 2006

Products on Application NDA 076822:

Active Ingredients	Strenght	Dosage Form	Marketing Status	TE Code
RABEPRAZOLE SODIUM	20MG	TABLET, DELAYED RELEASE; ORAL	Tentative approval	none

Welcome

Did you know it can take decades for medical innovations to be widely adopted by the healthcare community? To make the best decisions for your health, you need more information than your physician alone can provide. Medicine.org is here to help you become an advocate for your own health by allowing you to share and discover the current healthcare information you need. Learn more.

Navigation

Resources

Medical Dictionary

Drug Information

Events

«	December 2008
S	M	T	W	T	F	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

Who's online

There are currently 0 users and 575 guests online.

Job search

Find jobs in healthcare or try morejob search engines.

About | Privacy Statement | Terms & Conditions | Contact Us | Link Resources

Medicine.org is an online community where consumers can share health resources and information. It is intended to supplement, not replace, professional medical care. Always consult your doctor for medical advice related to your specific health condition.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.

Links to Site

last updated on 12-05-2008